FDA Approved: FUROSEMIDE — Supplemental Application (Ipca Laboratories Limited)

View source ↗

Summary

FDA approved a supplemental application for furosemide from Ipca Laboratories Limited under an ANDA, signaling approval of changes to the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hypertension
• Liver Cirrhosis with Ascites
• Renal Disease

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

SUPPL AP for FUROSEMIDE (FUROSEMIDE)